Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal NDUFA13 Primary Antibody for WB - ABIN537353
Patole, Pawar, Lech, Zecher, Schmidt, Segerer, Ellwart, Henger, Kretzler, Anders: Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006
Show all 5 Pubmed References
Human Polyclonal NDUFA13 Primary Antibody for IF, IHC (p) - ABIN526435
Kjellin, Johansson, Höög, Lehtiö, Jakobsson, Kjellman: Differentially expressed proteins in malignant and benign adrenocortical tumors. in PLoS ONE 2014
GRIM-19 suppresses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 (show STAT3 Antibodies) signaling.
Mitochondrial GRIM-19 could not only serve as an valuable prognostic biomarker for gastric cancer development, but also as a potential therapeutic target for STAT3 (show STAT3 Antibodies)-dependent carcinogenesis of Gastric cancer.
GRIM-19 expression in cervical cancer cells could inhibit telomerase activity by inhibiting the transactivation of the hTERT promoter by E6, thereby promoting cervical cancer cell senescence.
NDUFA13 deficiency may be associated with asthenozoospermia through the disturbance of spermatozoa mitochondrial membrane potential and by increasing apoptosis and intracellular reactive oxygen species
GRIM-19 overexpression suppressed hepatocellular carcinoma (HCC (show FAM126A Antibodies)) growth and downregulated AKT1 (show AKT1 Antibodies) expression, suggesting that GRIM-19 might play a crucial role in hepatocarcinogenesis through negatively regulating the PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies) signaling pathway.
Low GRIM-19 expression is associated with paclitaxel resistance in cervical cancer.
activation of AMPKalpha (show GRK4 Antibodies) by metformin was associated with a reversal of the suppressed GRIM-19 expression in H9C2 cells, the fold of changes in GRIM-19 expression by metformin were much less in HeLa cells
Data suggest that tumor expression of Ki67 (antigen Ki-67 (show MKI67 Antibodies)) and GRIM19 correlate with malignancy in thyroid Hurthle cell (HC) tumors; variable expression of Ki67 (show MKI67 Antibodies) and GRIM19 may helped differentiate HC carcinoma from HC adenoma.
Transfection with eukaryotic plasmid for the simultaneous expression of GRIM19 and LKB1 (show STK11 Antibodies) more effectively suppressed the growth of breast cancer in vitro and in vivo, and may therefore have therapeutic potential for the treatment of human breast cancer.
Aberrant endometrial expression of GRIM-19 was associated with adenomyosis through the regulation of apoptosis and angiogenesis.
At the basal state, a moderate down-regulation of NDUFA13 created a leak within complex I, resulting in a mild increase in cytoplasm localized Hydrogen Peroxide, but not superoxide. The resultant reactive oxygen species served as a second messenger and was responsible for the STAT3 (show STAT3 Antibodies) dimerization and, hence, the activation of antiapoptotic signaling.
iNGR-GRIM-19 has an efficient antitumor activity in vitro and in vivo, and might be a promising agent for the treatment of colorectal cancer.
Transplantation from GRIM19-overexpressing cells downregulated the expression of nuclear factor of activated T cells (NFATc1 (show NFATC1 Antibodies)) but promoted the expression of regulator of calcineurin (RCAN)3 (show RCAN3 Antibodies) while downregulating NFAT (show NFATC1 Antibodies)-dependent cytokine gene expression.
GRIM-19 may play important roles in mouse oogenesis and early embryonic development and implantation.
overexpression of GRIM-19 improved the clinical and histologic features of collagen-induced arthritis and also inhibited osteoclast formation.
The deletion of a single copy of the Grim-19 gene was sufficient to promote carcinogenesis and formation of invasive squamous cell carcinomas.
Tumor-derived mutations in the gene associated with retinoid interferon (show IFNA Antibodies)-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3 (show STAT3 Antibodies)) activity and promote oncogenesis
in vitro nona (show NONO Antibodies)-arginine-GRIM19 treatment of constitutively activated STAT3 (show STAT3 Antibodies) (STAT3c) cancer cells significantly reduced STAT3 (show STAT3 Antibodies)-dependent transcription.
Data show that restoration of GRIM-19 levels reestablishes the control over STAT3 (show STAT3 Antibodies)-dependent gene expression and tumor growth in vivo.
This gene encodes a subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), which functions in the transfer of electrons from NADH to the respiratory chain. The protein is required for complex I assembly and electron transfer activity. The protein binds the signal transducers and activators of transcription 3 (STAT3) transcription factor, and can function as a tumor suppressor. The human protein purified from mitochondria migrates at approximately 16 kDa. Transcripts originating from an upstream promoter and capable of expressing a protein with a longer N-terminus have been found, but their biological validity has not been determined.
cell death-regulatory protein GRIM19
, NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
, GRIM-19 protein
, mitochondrial NADH dehydrogenase ubiquinone 1 alpha subcomplex 13
, NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
, OXPHOS complex I B16.6 subunit
, NADH-ubiquinone oxidoreductase B16.6 subunit
, cell death regulatory protein GRIM-19
, complex I B16.6 subunit
, complex I-B16.6
, gene associated with retinoic and IFN-induced mortality 19 protein
, gene associated with retinoic and interferon-induced mortality 19 protein
, gene associated with retinoic-interferon-induced mortality 19 protein
, genes associated with retinoid-IFN-induced mortality 19
, YjeF N-terminal domain containing 3
, mitochondrial complex I subunit Grim19